Stanford University School of Medicine
Stanford, United States
Dr. Melanie Hayden Gephart is a board-certified brain tumor neurosurgeon, with a laboratory accelerating translational neuro-oncology research, combining genetics and tumor biology with a unique insight into the pressing clinical questions facing patients with malignant brain tumors. Her laboratory uses novel genetic sequencing methods and modeling to understand how cancer grows in the brain, inadvertently supported by native brain cells. They focus on translational targets identified from and validated with primary human tissue and cerebrospinal fluid whenever possible, as this most reliably recapitulates the human disease. These findings have led to novel diagnostic tools and clinical trials for patients with malignant brain tumors. She co-directs the Stanford Brain Tumor Center, and established the Stanford Brain Metastases Consortium, a multidisciplinary group of physicians and scientists collaborating to improve outcomes for patients with malignant brain tumors. www.GephartLab.com